Clinical Pharmaceutics
A section of Pharmaceutics (ISSN 1999-4923).
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Drug Design and Novel Biomarkers for the Treatment of Gastrointestinal Tumors (Deadline: 20 April 2024)
- Association Studies in Clinical Pharmacogenetics—Volume II (Deadline: 24 April 2024)
- Novel Therapeutic Strategies for Glioblastoma (Deadline: 31 May 2024)
- Drug Monitoring of Antibiotics in the Era of Precision Dosing (Deadline: 10 June 2024)
- Novel Anticancer Strategies (Volume III) (Deadline: 30 June 2024)
- Advances in the Pharmaceutical Treatment of Cardiovascular Disease (Deadline: 30 June 2024)
- Pharmaceutical Technology and Formulations for the Treatment of Eye Diseases (Deadline: 10 July 2024)
- Unveiling New Insights and Treatment Options for Ocular Surface Diseases (Deadline: 31 July 2024)
- Advances in Radiopharmaceuticals for Disease Diagnoses and Therapy (Deadline: 31 August 2024)
- Emerging Strategies in Drug Development and Clinical Care in the Era of Personalized and Precision Medicine, 2nd Edition (Deadline: 30 September 2024)
- Extemporaneous Formulations: Filling the Gap in the Pharmaceutical Industry with Personalized Medicines (Deadline: 31 December 2024)
